AU604806B2 - Antibiotic a10255 complex and factors, microorganisms, process and production therefor - Google Patents

Antibiotic a10255 complex and factors, microorganisms, process and production therefor

Info

Publication number
AU604806B2
AU604806B2 AU82493/87A AU8249387A AU604806B2 AU 604806 B2 AU604806 B2 AU 604806B2 AU 82493/87 A AU82493/87 A AU 82493/87A AU 8249387 A AU8249387 A AU 8249387A AU 604806 B2 AU604806 B2 AU 604806B2
Authority
AU
Australia
Prior art keywords
factor
complex
antibiotic
nrrl
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU82493/87A
Other languages
English (en)
Other versions
AU8249387A (en
Inventor
Laverne Dwaine Boeck
Otis Webster Godfrey Jr.
Marvin Martin Hoehn
Herbert Andrew Kirst
Karl Heinz Michel
Eugene Thomas Seno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU8249387A publication Critical patent/AU8249387A/en
Application granted granted Critical
Publication of AU604806B2 publication Critical patent/AU604806B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU82493/87A 1986-12-15 1987-12-14 Antibiotic a10255 complex and factors, microorganisms, process and production therefor Ceased AU604806B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US94189486A 1986-12-15 1986-12-15
US94147386A 1986-12-15 1986-12-15
US941473 1992-09-08
US941894 1997-09-30

Publications (2)

Publication Number Publication Date
AU8249387A AU8249387A (en) 1988-07-28
AU604806B2 true AU604806B2 (en) 1991-01-03

Family

ID=27130157

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82493/87A Ceased AU604806B2 (en) 1986-12-15 1987-12-14 Antibiotic a10255 complex and factors, microorganisms, process and production therefor

Country Status (15)

Country Link
EP (1) EP0274873B1 (enExample)
JP (1) JPS63258585A (enExample)
KR (1) KR880007553A (enExample)
CN (1) CN1023758C (enExample)
AU (1) AU604806B2 (enExample)
DE (1) DE3781878T2 (enExample)
DK (1) DK654987A (enExample)
ES (1) ES2052584T3 (enExample)
GR (1) GR3006408T3 (enExample)
HU (1) HU199559B (enExample)
IE (1) IE60394B1 (enExample)
IL (1) IL84819A (enExample)
MX (1) MX170925B (enExample)
NZ (1) NZ222895A (enExample)
PT (1) PT86364B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA879415B (en) * 1986-12-15 1989-08-30 Lilly Co Eli Antibiotic a10255 complex and factors,microorganisms,process and production therefor
US5229362A (en) * 1986-12-15 1993-07-20 Eli Lilly And Company Antibiotic A10255 complex and factors, and process and production therefor
ATE110784T1 (de) * 1987-06-19 1994-09-15 Sandoz Ag Zyklische peptolide.
IT1234197B (it) * 1988-06-14 1992-05-06 Mini Ricerca Scient Tecnolog Antibiotici ottenuti mediante coltivazione aerobica controllata dello streptomyces s.p. ncib 12629
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
KR20070120617A (ko) 2001-01-26 2007-12-24 쉐링 코포레이션 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
IL156445A0 (en) 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
EP1429756B1 (en) 2001-09-21 2006-11-22 Schering Corporation Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
CA2504916A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
US20070164132A1 (en) 2003-02-18 2007-07-19 Keith Laidler Spray nozzle
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
DE602004018617D1 (de) 2003-03-07 2009-02-05 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
WO2004081002A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
WO2004081004A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
EP2473516A1 (en) * 2009-09-02 2012-07-11 Piramal Life Sciences Limited Antibiotic compounds

Also Published As

Publication number Publication date
PT86364B (pt) 1990-11-07
JPS63258585A (ja) 1988-10-26
AU8249387A (en) 1988-07-28
NZ222895A (en) 1992-08-26
HUT49376A (en) 1989-09-28
IL84819A (en) 1993-07-08
IE873390L (en) 1988-06-15
PT86364A (en) 1988-01-01
HU199559B (en) 1990-02-28
MX170925B (es) 1993-09-22
GR3006408T3 (enExample) 1993-06-21
DK654987A (da) 1988-09-23
DE3781878T2 (de) 1993-03-11
ES2052584T3 (es) 1994-07-16
EP0274873A2 (en) 1988-07-20
KR880007553A (ko) 1988-08-27
EP0274873B1 (en) 1992-09-23
EP0274873A3 (en) 1989-08-09
DE3781878D1 (de) 1992-10-29
CN87108341A (zh) 1988-08-10
IE60394B1 (en) 1994-07-13
CN1023758C (zh) 1994-02-16
DK654987D0 (da) 1987-12-14

Similar Documents

Publication Publication Date Title
AU585807B2 (en) Hydroconversion process
AU584596B2 (en) Continuous bioreactor and process
AU3969689A (en) Bio-reactor cell culture process
AU7218887A (en) Hydroconversion process
AU589755B2 (en) Lubricant and process for its production
AU8249387A (en) Antibiotic a10255 complex and factors, microorganisms, process and production therefor
AU2906789A (en) Anaerobic digestion process
EG18796A (en) Process for production of avermectins and cultures therefor.
ZA879415B (en) Antibiotic a10255 complex and factors,microorganisms,process and production therefor
AU591719B2 (en) Benzylamine derivatives, process for production thereof, and use thereof
EP0228701A3 (en) 2-iodo-perfluoro-2-methylathanes, process for their production and their application
AU615633B2 (en) Knitting process
AU3644489A (en) Novel pigments, process for their production and their use
AU598531B2 (en) Antibiotic A42125 and process for its production
AU585161B2 (en) Micropropogation process
AU8225187A (en) Reduced-stability alpha-amylase and process for its production
HUT46077A (en) Process for the microbiological production of 9alpha-hydroxy-4-androsten-3,17-dione
AU634331B2 (en) A novel antibiotic alisamycin, a process for its production and its use
AU7480187A (en) 16alpha-methylation process
AU594806B2 (en) Benzothiazolones, and their production and use
EP0342341A3 (en) Process for producing antitumor antibiotic ll-e33288gamma2
AU3431384A (en) Anaerobic fermentation process
AU2096588A (en) Antibiotic A80577 and process for its production
GB8819758D0 (en) Production of 2-methyl-5-isopropyl-hexa-2,5-dien-1-al & of 2-methyl-5-isopropyl-hexa-2,4-dien-1-al in microorganisms
AU7015487A (en) Cytokinin production from microorganisms